224 related articles for article (PubMed ID: 29587959)
21. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
23. Prognostication in cancer of unknown primary (CUP): development of a prognostic algorithm in 311 cases and review of the literature.
Petrakis D; Pentheroudakis G; Voulgaris E; Pavlidis N
Cancer Treat Rev; 2013 Nov; 39(7):701-8. PubMed ID: 23566573
[TBL] [Abstract][Full Text] [Related]
24. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
[TBL] [Abstract][Full Text] [Related]
25. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
[TBL] [Abstract][Full Text] [Related]
26. [Cancer of unknown primary (CUP)-single-site, oligometastatic, and in the head and neck region].
Pouyiourou M; Regnery S; Bochtler T; Herfarth K; Krämer A
Radiologie (Heidelb); 2023 May; 63(5):358-365. PubMed ID: 36944857
[TBL] [Abstract][Full Text] [Related]
27. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
28. Survival outcomes following craniotomy for intracranial metastases from an unknown primary.
Gough M; Nielsen M; Coulter IC; Holliman D
Int J Clin Oncol; 2020 Aug; 25(8):1475-1482. PubMed ID: 32358736
[TBL] [Abstract][Full Text] [Related]
29. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
31. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
Greco FA; Hainsworth JD
Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
[TBL] [Abstract][Full Text] [Related]
32. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
Randén M; Rutqvist LE; Johansson H
Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP).
Schaffer AL; Pearson SA; Perez-Concha O; Dobbins T; Ward RL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM
PLoS One; 2020; 15(3):e0230373. PubMed ID: 32191753
[TBL] [Abstract][Full Text] [Related]
34. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
[TBL] [Abstract][Full Text] [Related]
35. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
Schapira DV; Jarrett AR
Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
[TBL] [Abstract][Full Text] [Related]
36. Carcinoma of unknown primary: focused evaluation.
Varadhachary GR
J Natl Compr Canc Netw; 2011 Dec; 9(12):1406-12. PubMed ID: 22157558
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
[TBL] [Abstract][Full Text] [Related]
38. Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer.
Economopoulou P; Mountzios G; Pavlidis N; Pentheroudakis G
Cancer Treat Rev; 2015 Jul; 41(7):598-604. PubMed ID: 26033502
[TBL] [Abstract][Full Text] [Related]
39. [Space-occupying lesions in the liver: incidence of adenocarcinoma metastases of unknown primary site].
Eickhoff A; Spiethoff A; Hartmann D; Jakobs R; Weickert U; Schilling D; Eickhoff JC; Bohrer MH; Riemann JF
Dtsch Med Wochenschr; 2007 Feb; 132(8):369-74. PubMed ID: 17299675
[TBL] [Abstract][Full Text] [Related]
40. Cancer of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2005 Jun; 54(3):243-50. PubMed ID: 15890271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]